Gelfand Y - Search Results

1

Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes.

Morecki S, Lindhofer H, Yacovlev E, Gelfand Y, Slavin S. Morecki S, et al. Among authors: gelfand y. Blood. 2006 Feb 15;107(4):1564-9. doi: 10.1182/blood-2005-07-2738. Epub 2005 Oct 18. Blood. 2006. PMID: 16234351 Free article.

2

Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients.

Morecki S, Gelfand Y, Levi S, Nagler A, Condiotti R, Nabet C, Ackerstein A, Slavin S. Morecki S, et al. Among authors: gelfand y. J Hematother. 1997 Apr;6(2):115-24. doi: 10.1089/scd.1.1997.6.115. J Hematother. 1997. PMID: 9131440

3

Induction of antitumor immunity by indomethacin.

Morecki S, Yacovlev E, Gelfand Y, Trembovler V, Shohami E, Slavin S. Morecki S, et al. Among authors: gelfand y. Cancer Immunol Immunother. 2000 Feb;48(11):613-20. doi: 10.1007/s002620050009. Cancer Immunol Immunother. 2000. PMID: 10663608 Free PMC article.

4

Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.

Morecki S, Yacovlev E, Gelfand Y, Uzi I, Slavin S. Morecki S, et al. Among authors: gelfand y. J Immunother. 2001 Mar-Apr;24(2):114-21. J Immunother. 2001. PMID: 11265768

5

Cell Therapy With Preimmunized Effector Cells Mismatched for Minor Histocompatible Antigens in the Treatment of a Murine Mammary Carcinoma.

Morecki S, Yacovlev E, Gelfand Y, Uzi I, Slavin S. Morecki S, et al. Among authors: gelfand y. J Immunother (1991). 2001 Mar;24(2):114-121. J Immunother (1991). 2001. PMID: 11449067

6

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.

Morecki S, Gelfand Y, Nagler A, Or R, Naparstek E, Varadi G, Engelhard D, Akerstein A, Slavin S. Morecki S, et al. Among authors: gelfand y. Bone Marrow Transplant. 2001 Aug;28(3):243-9. doi: 10.1038/sj.bmt.1703118. Bone Marrow Transplant. 2001. PMID: 11535991

7

Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes.

Slavin S, Ackerstein A, Morecki S, Gelfand Y, Cividalli G. Slavin S, et al. Among authors: gelfand y. Bone Marrow Transplant. 2001 Oct;28(8):795-8. doi: 10.1038/sj.bmt.1703223. Bone Marrow Transplant. 2001. PMID: 11781634

8

Intraportal and systemic allogeneic cell therapy in a murine model of hepatic metastatic breast cancer.

Panigrahi S, Yacovlev E, Gelfand Y, Schuger L, Slavin S, Morecki S. Panigrahi S, et al. Among authors: gelfand y. Cytokines Cell Mol Ther. 2002;7(3):99-106. doi: 10.1080/13684730310001661. Cytokines Cell Mol Ther. 2002. PMID: 12850809

9

Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.

Morecki S, Yacovlev E, Gelfand Y, Vilensky A, Slavin S. Morecki S, et al. Among authors: gelfand y. Biol Blood Marrow Transplant. 2004 Jan;10(1):40-8. doi: 10.1016/j.bbmt.2003.09.013. Biol Blood Marrow Transplant. 2004. PMID: 14752778 Free article.

10

Effect of KRN7000 on induced graft-vs-host disease.

Morecki S, Panigrahi S, Pizov G, Yacovlev E, Gelfand Y, Eizik O, Slavin S. Morecki S, et al. Among authors: gelfand y. Exp Hematol. 2004 Jul;32(7):630-7. doi: 10.1016/j.exphem.2004.04.005. Exp Hematol. 2004. PMID: 15246159 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters